Silver Book Fact

A biopsychosocial approach (i.e., one that takes into account physical, emotional, and environmental factors in the assessment and treatment of pain) has been found to improve the pain care of patients with a range of conditions including neuropathic and musculoskeletal pain.

Kerns R, Kassirer M, Otis J. Pain in Multiple Sclerosis: A biopsychosocial perspective. J Rehabil Res Dev. 2002; 39(2): 225-32. http://www.rehab.research.va.gov/jour/02/39/2/pdf/kerns.pdf

Reference

Title
Pain in Multiple Sclerosis: A biopsychosocial perspective
Publication
J Rehabil Res Dev
Publication Date
2002
Authors
Kerns R, Kassirer M, Otis J
Volume & Issue
Volume 39, Issue 2
Pages
225-32
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • In individuals with persistent low back pain, tanezumab, a humanized anti-nerve growth factor antibody, showed clinical and statistical analgesic efficacy that was superior to placebo and naproxen.  
  • Understanding the role of genetics in pain mechanisms is increasing and the potential now exists to conduct genome-wide screens in model organisms to look for pain-associated genes.  
  • Targeting A-type K+ channels in primary sensory neurons could provide a novel mechanism-based therapy for the treatment of bone cancer pain–one of the most severe types of chronic pain.  
  • Growth hormone treatment in patients with fibromyalgia is effective in reducing pain with sustained action over time.  
  • An opiate agonist often used for persistent pain, tramadol was found in one meta-analysis to significantly reduce neuropathic pain when compared to placebo.